Paras Healthcare Q2 FY27 PAT Jumps 3.3x YoY to ₹40.4 Cr; Revenue Up 22.8% to ₹510.9 Cr
Paras Healthcare released its Q2 and H1 FY27 investor presentation following its October 2026 listing. Q2 FY27 revenue from operations grew 22.8% YoY to ₹510.9 crore, driven by newer hospitals ramping up occupancy to 78.1%. Operating EBITDA grew 47.0% YoY to ₹120.2 crore with margins widening by 390 bps to 23.5%, while PAT increased 3.3x YoY to ₹40.4 crore. For H1 FY27, revenue reached ₹981.2 crore and PAT stood at ₹90.0 crore, with overall bed occupancy expanding to 73.0% across 1,502 operational beds.
உச்சம் நம்பிக்கை
என்ன மாறியதுParas Healthcare published its Q2 and H1 FY27 investor presentation, detailing operational metrics, cohort performance, and financial results.
ஏன் இது முக்கியம்Demonstrates operating leverage as newer hospital units turned profitable (EBITDA margin of 18.7% vs negative in Q2 FY26), driving consolidated margin expansion to 23.5%.
Q2 FY27 Revenue: ₹510.9 CrsQ2 FY27 Operating EBITDA: ₹120.2 CrsQ2 FY27 PAT: ₹40.4 CrsH1 FY27 Revenue: ₹981.2 CrsH1 FY27 PAT: ₹90.0 CrsTarget Bed Capacity by 2028: 3,011 Beds
📅 குறுகிய காலம்Strong operational turnaround in newer facilities and strong EBITDA margin expansion are likely to support positive market sentiment following the recent listing.
📈 நீண்ட காலம்The company's expansion roadmap targeting 3,011 beds by 2028 from 2,211 beds currently provides multi-year capacity growth visibility across North and East Indian healthcare markets.
⚠ அபாய எச்சரிக்கைகள்
- Elevated debt levels with total borrowings at ₹979.0 crore (current and non-current) as of Sept 2026
- Execution risks on upcoming greenfield/brownfield expansions in Gurugram and Ludhiana
👀 கவனிக்க வேண்டியவை
Track the ramp-up and margin sustainability of newer hospital cohorts (Ranchi, Udaipur, Srinagar, Kanpur) and execution progress on the upcoming Gurugram and Ludhiana expansion projects.
